NRG Therapeutics
Stevenage, United Kingdom · Biotechnology, Health Care, Therapeutics
NRG Therapeutics is a neuroscience drug discovery company building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and Amyotrophic Lateral Sclerosis (ALS), also known as motor neurone disease (MND).
Key facts
- Headquarters
- Stevenage, United Kingdom
- Employees
- Unknown
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- nrgtherapeutics.com
- Company page
Recent activity at NRG Therapeutics
- : NRG Therapeutics Appoints Claus Sundgreen as Chief Medical Officer
- : NRG Therapeutics Appoints Paul Thompson as Chief Development Officer
- : NRG raises $67 million for a small molecule aimed at Parkinson’s and ALS.
- : Nrg Therapeutics Announces £16 Million Series A To Advance Mitochondrial Therapeutics For Parkinson's And Als
NRG Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Funding Round | $67.0M |
| Nov 2022 | Series A | $16.0M |
Leadership
- Neil Miller, CEO
- Claus Sundgreen, Chief Medical Officer
- Paul Thompson, Chief Development Officer
- Grant Hawthorne, Founder
- Neil Miller, Founder
- Richard Rutter, CSO
Verified email and direct lines for NRG Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
NRG Therapeutics in the news
- NRG Therapeutics Announces a PET Biodistribution Trial of Lead Clinical Asset NRG5051 - Yahoo Finance UK (Oct 21, 2026)
- NRG Therapeutics Announces the Appointment of Claus Sundgreen M.D. as Chief Medical Officer - GlobeNewswire (Aug 03, 2026)
- NRG Therapeutics Announces First Participants Dosed in its - GlobeNewswire (Jan 08, 2026)
Companies similar to NRG Therapeutics
- Abcuro · Biotechnology, Health Care, Therapeutics
- ZoeNCure Therapeutics Pvt. Ltd · Biotechnology, Health Care, Therapeutics
- Amplifica Holdings Group · Biotechnology, Health Care, Therapeutics
- Oruka Therapeutics · Biotechnology, Health Care, Therapeutics
- Neurvati Neurosciences · Biotechnology, Health Care, Therapeutics
About NRG Therapeutics: questions and answers
What does NRG Therapeutics do?
NRG Therapeutics is a neuroscience drug discovery company building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and Amyotrophic Lateral Sclerosis (ALS), also known as motor neurone disease (MND).
Where is NRG Therapeutics headquartered?
NRG Therapeutics is headquartered in Stevenage, United Kingdom.
Has NRG Therapeutics raised funding?
Yes. Fundz has recorded 2 funding events for NRG Therapeutics. The most recent, Funding Round of $67.0M, was in Sep 2025.
Who leads NRG Therapeutics?
Neil Miller is a CEO at NRG Therapeutics.
What is the latest news on NRG Therapeutics?
On Aug 03, 2026, NRG Therapeutics Appoints Claus Sundgreen as Chief Medical Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy